Intellia Therapeutics Inc (NTLA)
21.86
-1.06
(-4.62%)
USD |
NASDAQ |
Apr 16, 16:00
21.80
-0.06
(-0.27%)
After-Hours: 18:06
Intellia Therapeutics Price to Book Value: 2.000 for April 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 15, 2024 | 2.098 |
| April 12, 2024 | 2.221 |
| April 11, 2024 | 2.289 |
| April 10, 2024 | 2.283 |
| April 09, 2024 | 2.387 |
| April 08, 2024 | 2.315 |
| April 05, 2024 | 2.268 |
| April 04, 2024 | 2.285 |
| April 03, 2024 | 2.286 |
| April 02, 2024 | 2.297 |
| April 01, 2024 | 2.491 |
| March 28, 2024 | 2.518 |
| March 27, 2024 | 2.473 |
| March 26, 2024 | 2.403 |
| March 25, 2024 | 2.455 |
| March 22, 2024 | 2.463 |
| March 21, 2024 | 2.530 |
| March 20, 2024 | 2.542 |
| March 19, 2024 | 2.529 |
| March 18, 2024 | 2.505 |
| March 15, 2024 | 2.590 |
| March 14, 2024 | 2.518 |
| March 13, 2024 | 2.624 |
| March 12, 2024 | 2.542 |
| March 11, 2024 | 2.703 |
| Date | Value |
|---|---|
| March 08, 2024 | 2.743 |
| March 07, 2024 | 2.747 |
| March 06, 2024 | 2.741 |
| March 05, 2024 | 2.768 |
| March 04, 2024 | 2.964 |
| March 01, 2024 | 2.989 |
| February 29, 2024 | 2.940 |
| February 28, 2024 | 3.002 |
| February 27, 2024 | 2.839 |
| February 26, 2024 | 2.531 |
| February 23, 2024 | 2.388 |
| February 22, 2024 | 2.487 |
| February 21, 2024 | 2.460 |
| February 20, 2024 | 2.485 |
| February 16, 2024 | 2.539 |
| February 15, 2024 | 2.521 |
| February 14, 2024 | 2.504 |
| February 13, 2024 | 2.342 |
| February 12, 2024 | 2.622 |
| February 09, 2024 | 2.500 |
| February 08, 2024 | 2.433 |
| February 07, 2024 | 2.309 |
| February 06, 2024 | 2.353 |
| February 05, 2024 | 2.200 |
| February 02, 2024 | 2.240 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.767
Minimum
Mar 16 2020
26.25
Maximum
Sep 03 2021
5.370
Average
3.468
Median
Jul 21 2023
Price to Book Value Benchmarks
| Moderna Inc | 2.868 |
| Regeneron Pharmaceuticals Inc | 3.779 |
| NeuroMetrix Inc | 0.3500 |
| Repligen Corp | 4.647 |
| Pacific Biosciences of California Inc | 0.5330 |
Price to Book Value Related Metrics
| PS Ratio | 53.87 |
| Price | 21.86 |
| Earnings Yield | -24.75% |
| Market Cap | 2.101B |